[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Aytu Biopharma Inc (AYTU)

Aytu Biopharma Inc (AYTU)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Aytu Biopharma Inc 7900 E. UNION AVENUE SUITE 920 DENVER CO 80237 USA

www.aytubio.com Employees: 83 P: 720-437-6580

Sector:

Medical

Description:

Aytu BioPharma Inc. is a pharmaceutical company focused on advancing medicines for complex central nervous system diseases to improve the quality of life for patients. Aytu BioPharma Inc., formerly known as AYTU BIOSCIENCE, is based in DENVER, CO.

Key Statistics

Overview:

Market Capitalization, $K 25,545
Enterprise Value, $K 16,415
Shares Outstanding, K 10,733
Float, K 10,207
% Float 95.10%
Short Interest, K 326
Short Float 3.04%
Days to Cover 12.49
Short Volume Ratio 0.47
% of Insider Shareholders 4.90%
% of Institutional Shareholders 33.49%

Financials:

Annual Sales, $ 66,380 K
Annual Net Income, $ -13,560 K
Last Quarter Sales, $ 12,410 K
Last Quarter Net Income, $ -5,620 K
EBIT, $ -4,240 K
EBITDA, $ 1,250 K

Growth:

1-Year Return 6.79%
3-Year Return 35.63%
5-Year Return -96.78%
5-Year Revenue Growth 140.25%
5-Year Earnings Growth 0.00%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.53 on 05/13/26
Next Earnings Date 09/22/26
Earnings Per Share ttm -1.92
EPS Growth vs. Prev Qtr 49.52%
EPS Growth vs. Prev Year -365.00%
Annual Dividend & Yield (Paid) 0.00 (0.00%)
Annual Dividend & Yield (Fwd) 0.00 (0.00%)
Dividend Payout Ratio 0.00%
Most Recent Split 1-20 on 01/06/23

AYTU Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward 9.20
Price/Earnings to Growth N/A
Return-on-Equity % -69.93%
Return-on-Assets % -13.25%
Profit Margin % -20.43%
Debt/Equity 0.62
Price/Sales 0.38
Price/Cash Flow 6.13
Price/Book 0.70
Book Value/Share 3.27
Interest Coverage -2.72
60-Month Beta 0.25
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.